Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012)

Q. Li, Y.T. Xiang, Y.A. Su, L. Shu, X. Yu, C.U. Correll, Gabor Ungvari, H.F.K. Chiu, C. Ma, G.H. Wang, P.S. Bai, T. Li, L.Z. Sun, J.G. Shi, X.S. Chen, Q.Y. Mei, K.Q. Li, T.M. Si, J.M. Kane

    Research output: Contribution to journalArticlepeer-review

    17 Citations (Scopus)

    Abstract

    © 2015 Elsevier B.V. Objective: We examined the time trends and correlates of clozapine use in schizophrenia patients in China. Method: A total of 14,013 patients with schizophrenia treated in 45 psychiatric hospitals/centers nationwide were interviewed in 2002, 2006 and 2012. Patients' socio-demographic and clinical characteristics including psychopathology, medication side effects, satisfaction with treatment and quality of life (QOL) were recorded in a standardized fashion. Results: Clozapine was used in 32.9% of the whole sample; with corresponding figures of 39.7%, 32.5% and 26.4% in 2002, 2006 and 2012 (p2=0.498, p
    Original languageEnglish
    Pages (from-to)523-529
    JournalSchizophrenia Research
    Volume168
    Issue number1-2
    DOIs
    Publication statusPublished - 2015

    Fingerprint

    Dive into the research topics of 'Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012)'. Together they form a unique fingerprint.

    Cite this